MCEMP1 and influenza: MCEMP1 showed a significantly higher expression in the NGR group than in the GR group, reaching the peak value at day 3 post-vaccination, highlighting the regulatory effect of dynamically expressed MCEMP1 on the safety and tolerability to the influenza vaccines.